These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 9177146

  • 1. Cancer biology in ulcerative colitis and potential use in endoscopic surveillance.
    Shapiro BD, Lashner BA.
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):453-68. PubMed ID: 9177146
    [Abstract] [Full Text] [Related]

  • 2. Chronic inflammatory bowel disease and cancer.
    Pohl C, Hombach A, Kruis W.
    Hepatogastroenterology; 2000 Jul; 47(31):57-70. PubMed ID: 10690586
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
    Brüwer M, Schmid KW, Senninger N, Schürmann G.
    World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
    [Abstract] [Full Text] [Related]

  • 4. Abnormal p53 immunohistochemistry is associated with an increased colorectal cancer-related mortality in patients with ulcerative colitis.
    Lashner BA, Bauer WM, Rybicki LA, Goldblum JR.
    Am J Gastroenterol; 2003 Jun; 98(6):1423-7. PubMed ID: 12818291
    [Abstract] [Full Text] [Related]

  • 5. Cancer surveillance in ulcerative colitis.
    Chambers WM, Warren BF, Jewell DP, Mortensen NJ.
    Br J Surg; 2005 Aug; 92(8):928-36. PubMed ID: 16034807
    [Abstract] [Full Text] [Related]

  • 6. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S, Fujimori T, Chiba T.
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis.
    Lashner BA, Shapiro BD, Husain A, Goldblum JR.
    Am J Gastroenterol; 1999 Feb; 94(2):456-62. PubMed ID: 10022646
    [Abstract] [Full Text] [Related]

  • 8. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T, Takayama T, Miyanishi K, Nobuoka A, Katsuki S, Sato Y, Takimoto R, Matsunaga T, Kato J, Sonoda T, Sakamaki S, Niitsu Y.
    Clin Cancer Res; 2008 Jan 01; 14(1):48-54. PubMed ID: 18172251
    [Abstract] [Full Text] [Related]

  • 9. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
    Rosman-Urbach M, Niv Y, Birk Y, Smirnoff P, Zusman I, Morgenstern S, Schwartz B.
    Dis Colon Rectum; 2004 Mar 01; 47(3):304-13. PubMed ID: 14991492
    [Abstract] [Full Text] [Related]

  • 10. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S, Panisić M, Tarabar D, Cuk V, Brajuković G, Petrović M.
    Acta Chir Iugosl; 2000 Mar 01; 47(1-2):43-50. PubMed ID: 10953365
    [Abstract] [Full Text] [Related]

  • 11. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis.
    Lindberg JO, Stenling RB, Rutegård JN.
    Br J Surg; 1999 Jul 01; 86(7):947-50. PubMed ID: 10417571
    [Abstract] [Full Text] [Related]

  • 12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS, Lin SR, Chang MY, Chen FM, Lu CY, Huang TJ, Huang YS, Huang CJ, Wang JY.
    Am Surg; 2005 Apr 01; 71(4):336-43. PubMed ID: 15943410
    [Abstract] [Full Text] [Related]

  • 13. [Colon cancer associated with ulcerative colitis and early diagnosis].
    Tsujikawa T, Bamba T.
    Nihon Rinsho; 1999 Nov 01; 57(11):2608-13. PubMed ID: 10572440
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis.
    Azarschab P, Porschen R, Gregor M, Blin N, Holzmann K.
    Genes Chromosomes Cancer; 2002 Oct 01; 35(2):121-6. PubMed ID: 12203775
    [Abstract] [Full Text] [Related]

  • 15. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J, McKinley M, Kahn E, Stiel L, Rosa J, Grancher K, Daum F.
    Am J Gastroenterol; 1997 Nov 01; 92(11):2001-6. PubMed ID: 9362180
    [Abstract] [Full Text] [Related]

  • 16. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R.
    Anticancer Res; 2004 Nov 01; 24(5B):3121-7. PubMed ID: 15510599
    [Abstract] [Full Text] [Related]

  • 17. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM, Heinzlmann M, Stratakis DF, Teschauer W, Loeschke K.
    Am J Gastroenterol; 1997 Dec 01; 92(12):2166-70. PubMed ID: 9399746
    [Abstract] [Full Text] [Related]

  • 18. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity.
    Awais D, Siegel CA, Higgins PD.
    Gut; 2009 Nov 01; 58(11):1498-503. PubMed ID: 19651634
    [Abstract] [Full Text] [Related]

  • 19. Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer.
    Levin B, Lennard-Jones J, Riddell RH, Sachar D, Winawer SJ.
    Bull World Health Organ; 1991 Nov 01; 69(1):121-6. PubMed ID: 1905205
    [Abstract] [Full Text] [Related]

  • 20. Cancer surveillance colonoscopy in ulcerative colitis: sense or nonsense?
    Schapiro M.
    Schweiz Med Wochenschr Suppl; 1996 Nov 01; 79():5S-8S. PubMed ID: 8701261
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.